BMEA Stock Price | Biomea Fusion Inc P/E, Revenue, EPS, & Forecasts

Biomea Fusion Inc • BMEA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Biomea Fusion Inc

Ticker

BMEA

Trading on

NASDAQ

ISIN

US09077A1060

Industry

Biotechnology

Sector

Healthcare

CEO

Headquarters

900 Middlefield Road, Redwood City, CA, United States, 94063

Employees

107

Website

https://biomeafusion.com

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Metrics

BasicAdvanced

Market cap

$101M

P/E ratio

EPS

-$4.01

Dividend Yield

0.00%

Beta

-0.28

Forward P/E ratio

EBIDTA

$-150M

Ex dividend date

Price & volume

Market cap

$101M

Average daily volume

0.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

1.33

Earnings

EPS

-$4.01

EPS estimate (current quarter)

-$0.95

EPS estimate (next quarter)

-$0.90

EBITDA

$-150M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

-0.28

52-week High

$16.29

52-week Low

$2.35

50-day moving average

$3.43

200-day moving average

$6.03

Short ratio

23.46

Short %

49.86%

Management effectiveness

ROE (TTM)

104.51%

ROA (TTM)

56.38%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

36.2M

Float

28.1M

Insiders %

25.02%

Institutions %

63.55%

Analyst Insights & forecasts

78% Buy

22% Hold

0% Sell

Based on information from 9 analysts.

Average price target

$23.67

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.98

-$0.85

15.29%

Q4 • 23Beat

-$1.09

-$0.99

10.10%

Q1 • 24Beat

-$1.03

-$1.07

3.74%

Q2 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-37.3M

∞%

Q2 • 24

$0M

$-32.8M

∞%

Q3 • 24

NaN%

12.04%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$136M

$32.2M

23.66%

Q2 • 24

$110M

$34.4M

31.20%

Q3 • 24

18.91%

6.93%

31.86%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-32.6M

$-0.1M

$1.1M

$-32.7M

Q2 • 24

$-25.2M

$-0.2M

$0.1M

$-25.4M

Q3 • 24

22.75%

215.25%

93.55%

22.32%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Biomea Fusion Inc share?

Biomea Fusion Inc shares are currently traded for undefined per share.

How many shares does Biomea Fusion Inc have?

Biomea Fusion Inc currently has 36.2M shares.

Does Biomea Fusion Inc pay dividends?

No, Biomea Fusion Inc doesn't pay dividends.

What is Biomea Fusion Inc 52 week high?

Biomea Fusion Inc 52 week high is $16.29.

What is Biomea Fusion Inc 52 week low?

Biomea Fusion Inc 52 week low is $2.35.

What is the 200-day moving average of Biomea Fusion Inc?

Biomea Fusion Inc 200-day moving average is $6.03.

Who is Biomea Fusion Inc CEO?

The CEO of Biomea Fusion Inc is -.

How many employees Biomea Fusion Inc has?

Biomea Fusion Inc has 107 employees.

What is the market cap of Biomea Fusion Inc?

The market cap of Biomea Fusion Inc is $101M.

What is the P/E of Biomea Fusion Inc?

The current P/E of Biomea Fusion Inc is null.

What is the EPS of Biomea Fusion Inc?

The EPS of Biomea Fusion Inc is -$4.01.

What is the PEG Ratio of Biomea Fusion Inc?

The PEG Ratio of Biomea Fusion Inc is null.

What do analysts say about Biomea Fusion Inc?

According to the analysts Biomea Fusion Inc is considered a buy.